COPD trials in France

In France 62 Also abroad 557

62 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Time of Exercise Re-training With Chronic Obstructive Pulmonary Disease (COPD)
Where
Lille
Age
18 years to 85 years
People
90
Run by
Michaël RACODON
See details and how to joinNCT06366113
No phaseNot yet taking people in France
The Aim of the Study is to Decipher the Alterations in Signalling Pathways of Skeletal Muscle Stem Cells (Satellite Cells (SCs)) in Individuals With COPD, as Well as to Examine the Effect of Exercise Training on SCs.
Where
Créteil, Paris, Pessac
Age
18 years to 75 years
People
26
Run by
University Hospital, Bordeaux
See details and how to joinNCT07923656
Phase 2Taking people
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
Where
Brest, Cholet, Créteil, La Tronche, Lyon Cedex 04, Marseille, Montpellier, Paris, Pessac, Toulouse, Vandoeuvre Les Nancy Cedex
Age
40 years to 75 years
People
606 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07759245 · EU 2026-525480-41-00
No phaseTaking people
Evaluation of Impaired Mobility in Chronic Illness Constitution of a Cohort
Where
Clermont-Ferrand
Age
18 years to 90 years
People
5,000
Run by
University Hospital, Clermont-Ferrand
See details and how to joinNCT04375280
No phaseTaking people
Combinaison of Virtual Reality and Rehabilitation to Improve Muscle Function, Exercise Tolerance, Exertional Symptoms and Dyspnea in Patients With Chronic Respiratory Disease: a Randomized Cross-over Trial
Where
Paris
Age
18 years and over
People
26
Run by
Fondation Hôpital Saint-Joseph
See details and how to joinNCT06811402
No phaseNot yet taking people in France
Impact of Multidisciplinary Care, Structured and Targeted on the COPD Patient's Clinical Pathway.
Where
Nîmes
Age
18 years and over
People
116
Run by
Centre Hospitalier Universitaire de Nīmes
See details and how to joinNCT07907601
No phaseTaking people
Characteristics and Outcomes of Patients Admitted to ICU for a Severe Acute Exacerbation of COPD.
Where
Grenoble, Le Chesnay, Le Mans, Rennes
Age
40 years and over
People
2,000
Run by
Alexis FERRE
See details and how to joinNCT06257329
Phase 2/3Taking people
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Where
Epagny Metz-tessy, Lyon Cedex 04, Montpellier, Paris
Age
35 years to 80 years
People
1,156 worldwide
Run by
Pfizer
See details and how to joinNCT07363694 · EU 2024-518587-12-00
Phase 4Taking people
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
Where
La Tronche, Lille, Lyon, Marseille, Montpellier, Pessac, Reims
Age
40 years to 85 years
People
218 worldwide
Run by
Sanofi
See details and how to joinNCT07053423
Phase 3Taking people
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Where
Brest, La Tronche, Le Mans, Lyon, Montpellier, Pessac, Pontoise, Reims, Suresnes, Vandœuvre-lès-Nancy
Age
40 years to 80 years
People
942 worldwide
Run by
Sanofi
See details and how to joinNCT07190209 · EU 2024-518016-39-00
Phase 3Taking people
Long-term Safety and Tolerability of Tozorakimab in Patients With COPD and History of Exacerbations
Where
Aix En Provence, Brest, Colmar Cedex, Epagny Metz-tessy, Grenoble Cedex 9, Lyon, Marseille, Montpellier Cedex 05, Pessac, Quimper Cedex, Saint-Herblain, Toulouse, Villefranche Sur Saone Cedex
Age
18 years to 99 years
People
59
Run by
AstraZeneca
See details and how to joinNCT07566195 · EU 2025-523690-41-00
Phase 3Taking people
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
Where
Brest, Lyon Cedex 04, Marseille, Montpellier, Paris, Paris Cedex 18, Pessac, Saint-Herblain, Strasbourg Cedex
Age
40 years to 80 years
People
990 worldwide
Run by
AstraZeneca
See details and how to joinNCT06878261 · EU 2024-517457-27-00
Phase 3Taking people
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
Where
Amiens, Amiens Cedex 1, Blois Cedex, Caen, Grenoble Cedex 9, Lyon Cedex 04, Marseille, Nice, Pessac, Saint-Herblain, Toulouse, Villeurbanne Cedex
Age
40 years to 80 years
People
981 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT06959095 · EU 2024-520418-22-00
Phase 3Taking people
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Where
Aix En Provence, Aurillac, Bayonne, Blois Cedex, Brest, Cannes Cedex, Cherbourg-En-Cotentin, Creteil Cedex, Grenoble Cedex 9, Laval, Le Coudray, Lomme Cedex, Lyon Cedex 04, Marseille, Mulhouse, Paris, Pessac, Pringy Cedex, Quint-Fonsegrives, Reims Cedex, Roscoff, Strasbourg Cedex, Trelaze, Vandoeuvre Les Nancy, Vannes, Villeurbanne
Age
40 years to 80 years
People
5,250 worldwide
Run by
AstraZeneca
See details and how to joinNCT06283966 · EU 2023-507407-59-00
No phaseTaking people
Comparison of Arterial and Capillary Blood Gas Analyses in Patients With Respiratory Distress Due to COPD or APE
Where
Nice
Age
18 years and over
People
65
Run by
Centre Hospitalier Universitaire de Nice
See details and how to joinNCT07835945
Phase 4Taking people
Chronic Airway Disease, Mucus Rheology and Exacerbations
Where
Bordeaux, Montpellier, Toulouse
Age
40 years to 85 years
People
72
Run by
University Hospital, Montpellier
See details and how to joinNCT04339270
No phaseTaking people
SPARK: Supporting Physical Activity Through Reality-Augmented Knowledge in COPD
Where
Montivilliers
Age
18 years and over
People
42
Run by
Groupe Hospitalier du Havre
See details and how to joinNCT07837375
No phaseTaking people
Long-term Real-world Study of Dupilumab in COPD : Patient Characteristics, Safety and Patient-reported Outcomes
Where
Aix-en-Provence, Antibes, Blois, Brest, Colmar, Contamine-sur-Arve, Évreux, La Tronche, Le Chesnay, Libourne, Lille, Lyon, Marseille, Montpellier, Morlaix, Nîmes, Niort, Paris, Pessac, Pierre-Bénite, Reims, Saint-Denis, Toulouse, Vantoux, Villeurbanne
Age
18 years and over
People
500
Run by
Sanofi
See details and how to joinNCT07380711
No phaseTaking people
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
Where
Limoges, Paris, Strasbourg, Toulouse
Age
40 years to 80 years
People
200 worldwide
Run by
Pulmonx Corporation
See details and how to joinNCT06035120
No phaseTaking people
Clinical Utility of LIBS Multi-Element Imaging and the IFF Algorithm in Chronic Lung Diseases
Where
Grenoble, Nancy, Rouen
Age
18 years and over
People
70
Run by
University Hospital, Grenoble
See details and how to joinNCT07597187
No phaseTaking people
Effect of Exercise Order During Pulmonary Rehabilitation on Muscle Strength in Patients With COPD
Where
Reims
Age
18 years and over
People
138
Run by
CHU de Reims
See details and how to joinNCT07655011
No phaseNot yet taking people in France
Creation of a Biological Collection of BRonchiaI and Pulmonary Tissues From Surgical wastE
Where
Pessac
Age
1 year to 80 years
People
650
Run by
University Hospital, Bordeaux
See details and how to joinNCT07780630
Phase 3Taking people
Tadalafil for Severe Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease
Where
Le Kremlin-Bicêtre
Age
18 years to 85 years
People
200
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT05844462
No phaseNot yet taking people in France
Factors Associated With Acceptance of Home-Based Pulmonary Telerehabilitation in COPD
Where
Rouen
Age
18 years and over
People
50
Run by
ADIR Association
See details and how to joinNCT07747571
No phaseNot yet taking people in France
Time Course of Respiratory Oscillometry Parameters During Nasal High-Flow Therapy in Stable Chronic Obstructive Pulmonary Disease
Where
Rouen
Age
18 years to 85 years
People
20
Run by
ADIR Association
See details and how to joinNCT07750613